Sale!

Tilidin AL comp 200mg/16mg

$110.00$790.00

Description

Tilidin AL comp 200mg/16mg

Tilidin AL comp 200mg/16mg is a combination medication containing two active ingredients: tilidine and naloxone. It is commonly use for the management of moderate to severe pain. Let’s break down the components of this medication:

  1. Tilidine: Tilidine is an opioid analgesic, meaning it belongs to the class of drugs that act on the opioid receptors in the central nervous system to relieve pain. It is often combine with naloxone to help reduce the risk of abuse and dependence.
  2. Naloxone: Naloxone is an opioid receptor antagonist. It works by blocking the effects of opioids, particularly in the gastrointestinal tract. When naloxone is combine with an opioid like tilidine, it is intende to deter misuse or abuse of the medication. If the medication is tampered with (crushed or injected), naloxone can counteract the opioid effects, making it less attractive for recreational use.

The combination of tilidine and naloxone in Tilidin AL comp is designe to provide pain relief while minimizing the risk of opioid abuse. This medication is typically prescribe by healthcare professionals and should be use under their guidance due to the potential for side effects and the risk of opioid-relate issue, such as dependence and respiratory depression.

As with any medication, it’s important to take Tilidin AL comp exactly as prescribe and to inform your healthcare provider about any other medications you may be taking to avoid potential drug interactions. Additionally, discuss any concerns or side effects with your healthcare provider promptly. Opioid medications, including those containing naloxone, should be use with caution and awareness of the potential risks associate with their use.

 

Additional information

packets

60 pills, 120 pills, 240 pills, 360 pills, 480 pills, 590 pills

Reviews

There are no reviews yet.

Be the first to review “Tilidin AL comp 200mg/16mg”

Your email address will not be published. Required fields are marked *